News Story: Full Text
Sponsored By
AbbVie
Please Click On The Above Banner For More Details
Braintumor Website

 

Proxima Therapeutics` GliaSite(R) Radiation Therapy System for Brain Tumors Receives Certificate for Inclusion in U.S. NRC Sealed Source and Device Registry (PR Newswire) Proxima Therapeutics, Inc., a privately held developer and maker of accelerated cancer treatments using internal radiation therapy, announced today that the State of Georgia Department of Natural Resources has issued a sealed source and device registration certificate for the company`s GliaSite RTS internal radiation treatment for brain tumors. - Sep 18 8:31 AM ET


IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/prnews/010918/hstu013_1.html


(Everything below this line is from VirtualTrials.com!)

Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740